002693 双成药业
已收盘 11-19 15:00:00
资讯
新帖
简况
双成药业:公司正在推进产线批量放大产能扩充工作
证券之星 · 11-18 20:51
双成药业:公司正在推进产线批量放大产能扩充工作
双成药业:公司部分研发活动属于《科技伦理审查办法(试行)》规定的审查范围
证券之星 · 11-18 20:51
双成药业:公司部分研发活动属于《科技伦理审查办法(试行)》规定的审查范围
双成药业(002693)11月18日主力资金净卖出319.87万元
证券之星 · 11-18 15:37
双成药业(002693)11月18日主力资金净卖出319.87万元
股市必读:双成药业新发布《海南双成药业股份有限公司第六届董事会第八次会议决议公告》
证券之星 · 11-16
股市必读:双成药业新发布《海南双成药业股份有限公司第六届董事会第八次会议决议公告》
双成药业(002693)披露2026年第四次临时股东会决议公告,11月13日股价下跌2.06%
证券之星 · 11-13
双成药业(002693)披露2026年第四次临时股东会决议公告,11月13日股价下跌2.06%
异动快报:双成药业(002693)11月12日10点50分触及涨停板
证券之星 · 11-12
异动快报:双成药业(002693)11月12日10点50分触及涨停板
股市必读:双成药业(002693)10月30日收盘跌5.11%,主力净流出725.04万元
证券之星 · 11-02
股市必读:双成药业(002693)10月30日收盘跌5.11%,主力净流出725.04万元
双成药业(002693)2026年三季报简析:营收净利润同比双双增长,应收账款上升
证券之星 · 10-31
双成药业(002693)2026年三季报简析:营收净利润同比双双增长,应收账款上升
双成药业(002693)9月30日股东户数4.29万户,较上期增加10.6%
证券之星 · 10-29
双成药业(002693)9月30日股东户数4.29万户,较上期增加10.6%
图解双成药业三季报:第三季度单季净利润同比下降44.68%
证券之星 · 10-29
图解双成药业三季报:第三季度单季净利润同比下降44.68%
股市必读:双成药业新发布《海南双成药业股份有限公司关于董事、高级管理人员减持计划期限届满暨实施情况的公告》
证券之星 · 10-26
股市必读:双成药业新发布《海南双成药业股份有限公司关于董事、高级管理人员减持计划期限届满暨实施情况的公告》
股市必读:双成药业新发布《海南双成药业股份有限公司关于董事、高级管理人员减持计划期限届满暨实施情况的公告》
证券之星 · 10-23
股市必读:双成药业新发布《海南双成药业股份有限公司关于董事、高级管理人员减持计划期限届满暨实施情况的公告》
双成药业(002693)10月19日主力资金净买入510.29万元
证券之星 · 10-19
双成药业(002693)10月19日主力资金净买入510.29万元
双成药业(002693)10月16日主力资金净卖出2920.09万元
证券之星 · 10-16
双成药业(002693)10月16日主力资金净卖出2920.09万元
双成药业(002693)10月14日主力资金净卖出6361.98万元
证券之星 · 10-14
双成药业(002693)10月14日主力资金净卖出6361.98万元
双成药业(002693)10月13日主力资金净买入9806.57万元
证券之星 · 10-13
双成药业(002693)10月13日主力资金净买入9806.57万元
异动快报:双成药业(002693)10月13日9点58分触及涨停板
证券之星 · 10-13
异动快报:双成药业(002693)10月13日9点58分触及涨停板
双成药业:10月9日高管袁剑琳、艾一祥减持股份合计4.8万股
证券之星 · 10-12
双成药业:10月9日高管袁剑琳、艾一祥减持股份合计4.8万股
双成药业(002693)10月9日主力资金净买入3147.57万元
证券之星 · 10-09
双成药业(002693)10月9日主力资金净买入3147.57万元
双成药业(002693)9月29日主力资金净买入508.85万元
证券之星 · 09-29
双成药业(002693)9月29日主力资金净买入508.85万元
公司概况
公司名称:
海南双成药业股份有限公司
所属行业:
医药制造业
上市日期:
2012-08-08
主营业务:
海南双成药业股份有限公司的主营业务是药品注射剂、固体制剂、原料药的研发、生产、销售。公司的主要产品是注射用紫杉醇(白蛋白结合型)。
发行价格:
20.00
{"stockData":{"symbol":"002693","market":"SZ","secType":"STK","nameCN":"双成药业","latestPrice":7.49,"timestamp":1795071783000,"preClose":7.76,"halted":0,"volume":15634600,"delay":0,"changeRate":-0.0348,"floatShares":411000000,"shares":415000000,"eps":0.1062,"marketStatus":"已收盘","change":-0.27,"latestTime":"11-19 15:00:00","open":7.77,"high":7.77,"low":7.31,"amount":117000000,"amplitude":0.0593,"askPrice":7.49,"askSize":91,"bidPrice":7.48,"bidSize":327,"shortable":0,"etf":0,"ttmEps":0.1062,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1795138200000},"marketStatusCode":5,"adr":0,"adjPreClose":7.76,"symbolType":"stock","openAndCloseTimeList":[[1795051800000,1795059000000],[1795064400000,1795071600000]],"highLimit":8.54,"lowLimit":6.98,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":414689750,"isCdr":false,"pbRate":7.4,"roa":"--","peRate":70.527307,"roe":"5.3%","epsLYR":0.05,"committee":0.248134,"marketValue":3106000000,"turnoverRate":0.038,"status":1,"floatMarketCap":3078000000},"requestUrl":"/m/hq/s/002693/wiki","defaultTab":"wiki","newsList":[{"id":"2684961349","title":"双成药业:公司正在推进产线批量放大产能扩充工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2684961349","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684961349?lang=zh_cn&edition=full","pubTime":"2026-11-18 20:51","pubTimestamp":1795006271,"startTime":"0","endTime":"0","summary":"证券之星消息,双成药业(002693)11月17日在投资者关系平台上答复投资者关心的问题。投资者提问:你好,摘帽问询函中提到的白蛋白紫杉醇新市场与新工厂的进度是否顺利,会逾期吗?双成药业回复:尊敬的投资者您好,公司正在推进产线批量放大产能扩充工作,不涉及您所提及的“新工厂”建设,感谢您对公司的关注。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111800041159.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684996158","title":"双成药业:公司部分研发活动属于《科技伦理审查办法(试行)》规定的审查范围","url":"https://stock-news.laohu8.com/highlight/detail?id=2684996158","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684996158?lang=zh_cn&edition=full","pubTime":"2026-11-18 20:51","pubTimestamp":1795006270,"startTime":"0","endTime":"0","summary":"请问公司研发活动是否属于《科技伦理审查办法(试行)》规定的审查范围?公司部分研发活动属于《科技伦理审查办法(试行)》规定的审查范围,公司研发活动涉及到伦理审查项目时会成立该项目存续期间临时科技伦理(审查)委员会参与伦理审查,主要组成人员包括公司总经理,研发副总,临床注册专员,以及和我们合作临床机构伦理委员会专家组成,人数约5-10人。以评估公司研发活动是否符合相关法规要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111800041158.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684968095","title":"双成药业(002693)11月18日主力资金净卖出319.87万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2684968095","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684968095?lang=zh_cn&edition=full","pubTime":"2026-11-18 15:37","pubTimestamp":1794987453,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月18日收盘,双成药业报收于7.76元,下跌4.32%,换手率4.35%,成交量17.88万手,成交额1.41亿元。11月18日的资金流向数据方面,主力资金净流出319.87万元,占总成交额2.27%,游资资金净流出178.85万元,占总成交额1.27%,散户资金净流入498.71万元,占总成交额3.54%。双成药业主营业务:涵盖药品注射剂、原料药的研发、生产、销售等。通过逐笔交易单成交金额计算主力资金流向、游资资金流向和散户资金流向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111800025312.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683665214","title":"股市必读:双成药业新发布《海南双成药业股份有限公司第六届董事会第八次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2683665214","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683665214?lang=zh_cn&edition=full","pubTime":"2026-11-16 01:20","pubTimestamp":1794763222,"startTime":"0","endTime":"0","summary":"公司公告汇总海南双成药业股份有限公司第六届董事会第八次会议决议公告海南双成药业股份有限公司于2026年11月13日召开第六届董事会第八次会议,审议通过《关于注销意大利全资子公司的议案》,同意注销意大利全资子公司,授权经营管理层负责清算注销事宜;表决结果为同意5票,反对0票,弃权0票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111600000457.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683061115","title":"双成药业(002693)披露2026年第四次临时股东会决议公告,11月13日股价下跌2.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2683061115","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683061115?lang=zh_cn&edition=full","pubTime":"2026-11-13 22:07","pubTimestamp":1794578838,"startTime":"0","endTime":"0","summary":"截至2026年11月13日收盘,双成药业报收于8.55元,较前一交易日下跌2.06%,最新总市值为35.46亿元。该股当日开盘8.61元,最高9.15元,最低8.46元,成交额达4.89亿元,换手率为13.45%。近日,海南双成药业股份有限公司发布《2026年第四次临时股东会决议公告》。公告显示,公司于2026年11月13日召开2026年第四次临时股东会,会议采用现场与网络投票相结合方式召开,出席会议股东共237人,代表股份占公司有表决权股份总数的2.5397%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111300043049.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682532166","title":"异动快报:双成药业(002693)11月12日10点50分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2682532166","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682532166?lang=zh_cn&edition=full","pubTime":"2026-11-12 10:55","pubTimestamp":1794452125,"startTime":"0","endTime":"0","summary":"证券之星11月12日盘中消息,10点50分双成药业(002693)触及涨停板。其所属行业化学制药目前上涨。领涨股为华纳药厂。该股为肝炎概念,海南概念,医药概念热股,当日肝炎概念概念上涨0.52%,海南概念概念上涨0.43%,医药概念上涨0.41%。11月11日的资金流向数据方面,主力资金净流出689.81万元,占总成交额9.98%,游资资金净流出130.87万元,占总成交额1.89%,散户资金净流入820.68万元,占总成交额11.88%。近5日资金流向一览见下表:双成药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111200012773.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680788442","title":"股市必读:双成药业(002693)10月30日收盘跌5.11%,主力净流出725.04万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680788442","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680788442?lang=zh_cn&edition=full","pubTime":"2026-11-02 06:45","pubTimestamp":1793573119,"startTime":"0","endTime":"0","summary":"截至2026年10月30日收盘,双成药业报收于7.8元,下跌5.11%,换手率4.2%,成交量17.26万手,成交额1.38亿元。交易信息汇总股价提醒10月30日双成药业收盘报7.8元,跌5.11%,当日成交1.38亿元;前10个交易日主力资金累计净流出2238.14万元,股价累计下跌5.11%。资金流向10月30日主力资金净流出725.04万元,占总成交额5.25%;游资资金净流出579.84万元,占总成交额4.2%;散户资金净流入1304.89万元,占总成交额9.44%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200001788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679250492","title":"双成药业(002693)2026年三季报简析:营收净利润同比双双增长,应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2679250492","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679250492?lang=zh_cn&edition=full","pubTime":"2026-10-31 07:47","pubTimestamp":1793404036,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期双成药业发布2026年三季报。截至本报告期末,公司营业总收入1.92亿元,同比上升13.6%,归母净利润2244.8万元,同比上升989.57%。按单季度数据看,第三季度营业总收入7471.92万元,同比下降11.87%,第三季度归母净利润882.02万元,同比下降44.68%。本报告期双成药业应收账款上升,应收账款同比增幅达82.56%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100017002.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679031104","title":"双成药业(002693)9月30日股东户数4.29万户,较上期增加10.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679031104","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679031104?lang=zh_cn&edition=full","pubTime":"2026-10-29 19:07","pubTimestamp":1793272069,"startTime":"0","endTime":"0","summary":"证券之星消息,近日双成药业披露,截至2026年9月30日公司股东户数为4.29万户,较6月30日增加4106.0户,增幅为10.6%。在化学制药行业个股中,双成药业股东户数高于行业平均水平,截至9月30日,化学制药行业平均股东户数为3.95万户。从股价来看,2026年6月30日至2026年9月30日,双成药业区间跌幅为2.54%,在此期间股东户数增加4106.0户,增幅为10.6%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900045883.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679154114","title":"图解双成药业三季报:第三季度单季净利润同比下降44.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679154114","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679154114?lang=zh_cn&edition=full","pubTime":"2026-10-29 03:42","pubTimestamp":1793216544,"startTime":"0","endTime":"0","summary":"证券之星消息,双成药业2026年三季报显示,前三季度公司主营收入1.92亿元,同比上升13.6%;归母净利润2244.8万元,同比上升989.57%;扣非净利润1557.63万元,同比上升365.53%;其中2026年第三季度,公司单季度主营收入7471.92万元,同比下降11.87%;单季度归母净利润882.02万元,同比下降44.68%;单季度扣非净利润467.67万元,同比下降69.13%;负债率47.07%,投资收益-0.02万元,财务费用1099.35万元,毛利率52.6%。财报数据概要请见下图:本文数据来源于双成药业2026年三季报,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900003855.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678131049","title":"股市必读:双成药业新发布《海南双成药业股份有限公司关于董事、高级管理人员减持计划期限届满暨实施情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2678131049","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678131049?lang=zh_cn&edition=full","pubTime":"2026-10-26 07:01","pubTimestamp":1792969273,"startTime":"0","endTime":"0","summary":"截至2026年10月23日收盘,双成药业报收于9.07元,上涨1.0%,换手率4.48%,成交量18.4万手,成交额1.63亿元。公司公告汇总海南双成药业股份有限公司关于董事、高级管理人员减持计划期限届满暨实施情况的公告海南双成药业股份有限公司于2026年6月30日披露部分董事、高级管理人员减持股份预披露公告,计划在2026年7月22日至10月21日期间通过集中竞价方式减持公司股份合计不超过442,525股。截至2026年10月21日,减持计划期限届满。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600001728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677599167","title":"股市必读:双成药业新发布《海南双成药业股份有限公司关于董事、高级管理人员减持计划期限届满暨实施情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2677599167","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677599167?lang=zh_cn&edition=full","pubTime":"2026-10-23 04:35","pubTimestamp":1792701309,"startTime":"0","endTime":"0","summary":"公司公告汇总海南双成药业股份有限公司关于董事、高级管理人员减持计划期限届满暨实施情况的公告LI JIANMING、袁剑琳、艾一祥、王蕊于2026年7月22日至10月21日期间,分别减持240,000股、81,000股、18,000股、15,525股;减持价格区间分别为9.35–10.32元/股、9.64–10.08元/股、9.80–9.81元/股、10.32元/股;减持后持股数量相应减少,减持过程遵守相关承诺及规定,未发生违规行为。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300004480.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676505440","title":"双成药业(002693)10月19日主力资金净买入510.29万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676505440","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676505440?lang=zh_cn&edition=full","pubTime":"2026-10-19 15:32","pubTimestamp":1792395126,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月19日收盘,双成药业报收于9.09元,下跌3.5%,换手率8.53%,成交量35.05万手,成交额3.16亿元。10月19日的资金流向数据方面,主力资金净流入510.29万元,占总成交额1.62%,游资资金净流出1483.73万元,占总成交额4.7%,散户资金净流入973.44万元,占总成交额3.08%。双成药业主营业务:涵盖药品注射剂、原料药的研发、生产、销售等。通过逐笔交易单成交金额计算主力资金流向、游资资金流向和散户资金流向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900013464.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675614155","title":"双成药业(002693)10月16日主力资金净卖出2920.09万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675614155","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675614155?lang=zh_cn&edition=full","pubTime":"2026-10-16 15:29","pubTimestamp":1792135791,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月16日收盘,双成药业报收于9.42元,下跌5.14%,换手率10.36%,成交量42.57万手,成交额4.13亿元。10月16日的资金流向数据方面,主力资金净流出2920.09万元,占总成交额7.06%,游资资金净流入1232.64万元,占总成交额2.98%,散户资金净流入1687.44万元,占总成交额4.08%。双成药业主营业务:涵盖药品注射剂、原料药的研发、生产、销售等。通过逐笔交易单成交金额计算主力资金流向、游资资金流向和散户资金流向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600020996.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675486319","title":"双成药业(002693)10月14日主力资金净卖出6361.98万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675486319","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675486319?lang=zh_cn&edition=full","pubTime":"2026-10-14 15:31","pubTimestamp":1791963100,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月14日收盘,双成药业报收于9.77元,下跌5.33%,换手率13.05%,成交量53.62万手,成交额5.36亿元。10月14日的资金流向数据方面,主力资金净流出6361.98万元,占总成交额11.87%,游资资金净流入886.25万元,占总成交额1.65%,散户资金净流入5475.73万元,占总成交额10.22%。双成药业主营业务:涵盖药品注射剂、原料药的研发、生产、销售等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400020867.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675339563","title":"双成药业(002693)10月13日主力资金净买入9806.57万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675339563","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675339563?lang=zh_cn&edition=full","pubTime":"2026-10-13 15:27","pubTimestamp":1791876451,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月13日收盘,双成药业报收于10.32元,上涨10.02%,换手率7.77%,成交量31.95万手,成交额3.17亿元。10月13日的资金流向数据方面,主力资金净流入9806.57万元,占总成交额30.95%,游资资金净流出4344.74万元,占总成交额13.71%,散户资金净流出5461.82万元,占总成交额17.24%。双成药业主营业务:涵盖药品注射剂、原料药的研发、生产、销售等。通过逐笔交易单成交金额计算主力资金流向、游资资金流向和散户资金流向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300020240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675381758","title":"异动快报:双成药业(002693)10月13日9点58分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2675381758","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675381758?lang=zh_cn&edition=full","pubTime":"2026-10-13 10:01","pubTimestamp":1791856863,"startTime":"0","endTime":"0","summary":"证券之星10月13日盘中消息,9点58分双成药业(002693)触及涨停板。其所属行业化学制药目前下跌。领涨股为灵康药业。该股为海南概念,肝炎概念,医药概念热股。10月12日的资金流向数据方面,主力资金净流出1642.67万元,占总成交额5.16%,游资资金净流入1466.65万元,占总成交额4.61%,散户资金净流入176.02万元,占总成交额0.55%。近5日资金流向一览见下表:双成药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300011023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674580880","title":"双成药业:10月9日高管袁剑琳、艾一祥减持股份合计4.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674580880","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674580880?lang=zh_cn&edition=full","pubTime":"2026-10-12 21:01","pubTimestamp":1791810071,"startTime":"0","endTime":"0","summary":"证券之星消息,根据10月12日市场公开信息、上市公司公告及交易所披露数据整理,双成药业(002693)最新董监高及相关人员股份变动情况:2026年10月9日公司高管袁剑琳、高管艾一祥共减持公司股份4.8万股,占公司总股本为0.0115%。变动期间公司股价上涨7.69%,10月9日当日收盘报9.8元。双成药业近半年内的董监高及核心技术人员增减持详情如下:双成药业的高管列表及最新持股情况如下:该股最近90天内无机构评级。本文数据来源于深圳证券交易所信息披露、双成药业公告,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200032993.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674390088","title":"双成药业(002693)10月9日主力资金净买入3147.57万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674390088","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674390088?lang=zh_cn&edition=full","pubTime":"2026-10-09 15:27","pubTimestamp":1791530855,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月9日收盘,双成药业报收于9.8元,上涨7.69%,换手率11.7%,成交量48.08万手,成交额4.63亿元。10月9日的资金流向数据方面,主力资金净流入3147.57万元,占总成交额6.79%,游资资金净流入1339.66万元,占总成交额2.89%,散户资金净流出4487.22万元,占总成交额9.68%。双成药业主营业务:涵盖药品注射剂、原料药的研发、生产、销售等。通过逐笔交易单成交金额计算主力资金流向、游资资金流向和散户资金流向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900018605.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671291115","title":"双成药业(002693)9月29日主力资金净买入508.85万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671291115","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671291115?lang=zh_cn&edition=full","pubTime":"2026-09-29 15:36","pubTimestamp":1790667411,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年9月29日收盘,双成药业报收于8.96元,下跌1.54%,换手率2.94%,成交量12.09万手,成交额1.09亿元。9月29日的资金流向数据方面,主力资金净流入508.85万元,占总成交额4.65%,游资资金净流出26.37万元,占总成交额0.24%,散户资金净流出482.48万元,占总成交额4.41%。双成药业主营业务:涵盖药品注射剂、原料药的研发、生产、销售等。通过逐笔交易单成交金额计算主力资金流向、游资资金流向和散户资金流向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900020600.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1795114741314,"stockEarnings":[{"period":"1week","weight":-0.142},{"period":"1month","weight":-0.1787},{"period":"3month","weight":-0.204},{"period":"6month","weight":-0.29},{"period":"1year","weight":-0.0684},{"period":"ytd","weight":0.0761}],"compareEarnings":[{"period":"1week","weight":-0.0214},{"period":"1month","weight":-0.0422},{"period":"3month","weight":-0.0839},{"period":"6month","weight":-0.1301},{"period":"1year","weight":-0.0935},{"period":"ytd","weight":-0.0986}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"海南双成药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"42851人(较上一季度增加10.60%)","perCapita":"9590股","listingDate":"2012-08-08","address":"海南省海口市秀英区兴国路16号","registeredCapital":"41468万元","survey":" 海南双成药业股份有限公司的主营业务是药品注射剂、固体制剂、原料药的研发、生产、销售。公司的主要产品是注射用紫杉醇(白蛋白结合型)。","listedPrice":20},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"双成药业(002693)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供双成药业(002693)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"双成药业,002693,双成药业股票,双成药业股票老虎,双成药业股票老虎国际,双成药业行情,双成药业股票行情,双成药业股价,双成药业股市,双成药业股票价格,双成药业股票交易,双成药业股票购买,双成药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"双成药业(002693)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供双成药业(002693)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}